HAVCR2 and breast cancer: T-cell immunoglobulin and mucin domain-containing molecule 3 (TIM-3), initially identified based upon its expression on CD4+ Th1 cells and CTL [94], is another immune checkpoint modulator that contributes to immune suppression in BC [95].